-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which regulatory T cells (T reg ) play a protective role in many inflammatory and autoimmune diseases including SLE
Regulatory T cells (T reg ) are protective in many inflammatory and autoimmune diseases, including SLE
+ + + + + + + + + + +
In the present study, we further investigated the molecular and cellular phenotypes of pCon-induced CD4 + and CD8 +T reg
+ + reg reg high high and l ow subsets high low low low low high reg
We found that pCons significantly increased the percentage of CD8 + FoxP3 + T cells and further increased the mean fluorescence intensity (MFI) of FoxP3, healthy peripheral blood mononuclear cells (pmcs) treated with pCons (10mg/ml, 24-48 hours)
+ + + + +
These data suggest that pCons stimulate cellular, immune, and molecular changes in regulatory T cells that protect against SLE autoimmunity
These data suggest that pCons stimulate cellular, immune, and molecular changes in regulatory T cells that protect against SLE autoimmunity
Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8 and CD4 Regulatory T Cells in Lupus.
leave a message here